Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Approximately 30% of people aged 65 years and older experience breathlessness (perceived respiratory difficulty) during daily activity. The main causes of increased breathlessness in the healthy elderly are poorly understood and are the main focus of the proposed study. Some possible contributing factors include abnormalities in the control and/or mechanics of breathing. To evaluate these possible contributory factors, the investigators will compare ventilatory and perceptual responses to: 1) exercise, 2) increased levels of inspired carbon dioxide, and 3) reduced levels of inspired oxygen under strictly-controlled experimental conditions where the investigators increase or decrease breathing requirements by altering dietary salt intake in healthy 40-80 year old men and women.
Exercise and rebreathing tests will be performed at baseline and at the end of each 3 day treatment period. Breathlessness intensity will be measured and compared at a standardized work rate, ventilation or end-tidal PCO2 during these tests.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Placebo Comparator | 0.025 g/kg/day of NaCl (sodium chloride) |
|
| High salt diet | Active Comparator | 0.2 g/kg/day of NH4Cl (ammonium chloride) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NH4Cl (ammonium chloride) | Dietary Supplement | 0.2 g/kg/day of NH4Cl (ammonium chloride) |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Breathlessness intensity (10-point Borg scale) | Measured at the end of each 3 day treatment period |
| Measure | Description | Time Frame |
|---|---|---|
| Exercise capacity (peak VO2) | Measured at the end of each 3 day treatment period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Denis E O'Donnell, MD, FRCPC | Queen's University and Kingston General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Respiratory Investigation Unit at Kingston General Hospital | Kingston | Ontario | K7L 2V7 | Canada |
Not provided
| ID | Term |
|---|---|
| D004417 | Dyspnea |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000643 | Ammonium Chloride |
| ID | Term |
|---|---|
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo |
| Dietary Supplement |
0.025 g/kg/day of NaCl (sodium chloride) |
|
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |
| D064751 |
| Ammonium Compounds |
| D017672 | Nitrogen Compounds |